%0 Journal Article
%T Evaluation of vascular accesses in the neonatal intensive care unit. Is the midline catheter a useful long-term alternative?
%A Sánchez García AT
%A Lozano González J
%A Canals Candela FJ
%J Med Intensiva (Engl Ed)
%V 0
%N 0
%D 2024 Jun 26
%M 38937197
暂无%R 10.1016/j.medine.2024.05.016
%X <B>OBJECTIVE: </B>Analyze the usefulness of the midline catheter in terms of efficacy and safety for treatments lasting more than 3 days in the neonatal population requiring admission to the NICU.<BR><B>METHODS: </B>Analytical and observational of a prospective cohort (December 2021-November 2023) compared to a historical cohort (January 2020-November 2021).<BR><B>METHODS: </B>9-bed Neonatal Intensive Care Unit (NICU, level III hospital.<BR><B>METHODS: </B>288, 66 midline group and 222 control group.<BR><B>METHODS: </B>newborns from 24 to 42 weeks of gestation who required short peripheral or midline cannulation and treatment longer than 3 days.<BR><B>METHODS: </B>Follow-up during NICU stay and comparison with retrospective data from a historical cohort.<BR><B>METHODS: </B>Sociodemographics, success rate (permanence of the same vascular catheter without complications until finish the prescribed treatment), number of catheters, cannulation rate per patient, indwell time, complications.<BR><B>RESULTS: </B>The midline group showed a higher success rate (54.2% vs 5.6%, p < 0.001), a lower number of canalizations per patient (p < 0.001), a longer indwell time (p < 0.001) and a lower number of extravasations (p < 0.001).<BR><B>CONCLUSIONS: </B>The midline catheter has advantages over short peripheral catheters, being a useful alternative in terms of efficacy and safety for treatments lasting more than 3 days in the neonatal population that requires admission to the NICU.